Science & Technology
Oral Therapeutics Platform for Treating Inborn Errors of Amino Acid Metabolism
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R44DK142244-01
Award Ceiling
$325K
Award Floor
$325K
Close Date
Jul 31, 2026
138 days leftTotal Funding
$325K
Expected Awards
1
Posted Date
Aug 1, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-1R44DK142244-01
Description
SBIR Phase Phase I award: "Oral Therapeutics Platform for Treating Inborn Errors of Amino Acid Metabolism" awarded to SYNTIS BIO INC in Boston, Massachusetts. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $324,984. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.